View in EDS HTML Full Text PDF Full Text

Cost-Utility Analysis of Faricimab Versus Aflibercept in Treating Neovascular Age-Related Macular Degeneration (nAMD) in the United States.

Saved in:
Bibliographic Details
Title: Cost-Utility Analysis of Faricimab Versus Aflibercept in Treating Neovascular Age-Related Macular Degeneration (nAMD) in the United States.
Authors: Baljoon, Ahmead1 (AUTHOR), Diaby, Vakaramoko2 (AUTHOR), Suther, Sandra1 (AUTHOR), Dutton, Matthew1 (AUTHOR), Ali, Askal1 (AUTHOR), Eljilany, Islam3 (AUTHOR) islam.eljilany@hotmail.com
Source: PharmacoEconomics - Open. May2026, Vol. 10 Issue 3, p457-469. 13p.
Database: Business Source Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: bsu
DbLabel: Business Source Ultimate
An: 193949881
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Cost-Utility Analysis of Faricimab Versus Aflibercept in Treating Neovascular Age-Related Macular Degeneration (nAMD) in the United States.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Baljoon%2C+Ahmead%22">Baljoon, Ahmead</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Diaby%2C+Vakaramoko%22">Diaby, Vakaramoko</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Suther%2C+Sandra%22">Suther, Sandra</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dutton%2C+Matthew%22">Dutton, Matthew</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ali%2C+Askal%22">Ali, Askal</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Eljilany%2C+Islam%22">Eljilany, Islam</searchLink><relatesTo>3</relatesTo> (AUTHOR)<i> islam.eljilany@hotmail.com</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22PharmacoEconomics+-+Open%22">PharmacoEconomics - Open</searchLink>. May2026, Vol. 10 Issue 3, p457-469. 13p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=bsu&AN=193949881
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s41669-026-00643-0
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 13
        StartPage: 457
    Titles:
      – TitleFull: Cost-Utility Analysis of Faricimab Versus Aflibercept in Treating Neovascular Age-Related Macular Degeneration (nAMD) in the United States.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Baljoon, Ahmead
      – PersonEntity:
          Name:
            NameFull: Diaby, Vakaramoko
      – PersonEntity:
          Name:
            NameFull: Suther, Sandra
      – PersonEntity:
          Name:
            NameFull: Dutton, Matthew
      – PersonEntity:
          Name:
            NameFull: Ali, Askal
      – PersonEntity:
          Name:
            NameFull: Eljilany, Islam
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: May2026
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 25094254
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: PharmacoEconomics - Open
              Type: main
ResultId 1